Looks like we're all stunned into silence. You look to be in the enviable position, OC, of not having to make a decision re the rights issue. .. On the face of it, it would seem foolhardy to take up the entitlement when the auditor (in the ann report) points out a cash burn of >$3m in the year to end June, and raises doubt even about the company's on going viability.
But then I have no knowledge of a Gandel Metals investment failing in the past. Surely the company has another plan to increase funds beyond the rights issue. .. Those who invested in the IPO at 25c (just a few years ago) must be very despondent - if they haven't already realized their losses. Good luck everyone whatever your decision
- Forums
- ASX - By Stock
- ORS
- 500 mill
500 mill, page-6
Featured News
Add ORS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online